Chia-Hsuan Tan1, Antoine Labbé2, Qingfeng Liang1, Liya Qiao1, Christophe Baudouin3, Xiuhua Wan1, Ningli Wang1. 1. Beijing Institute of Ophthalmology Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China. 2. Beijing Institute of Ophthalmology Beijing Tongren Eye Center, Beijing Tongren Hospital, Capital Medical University, Beijing, China 2Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, Paris and Versailles Saint-Quentin-en-Yvelin. 3. Department of Ophthalmology 3, Quinze-Vingts National Ophthalmology Hospital, Paris and Versailles Saint-Quentin-en-Yvelines University, Versailles, France 3Center for Clinical Investigations, INSERM 503, Quinze-Vingts National Ophthalmology Hospital, Par.
Abstract
PURPOSE: To evaluate the dynamic changes of optical quality in patients with dry eye disease (DED) by using a double-pass system. METHODS: Fifty-six patients with DED and 35 control subjects were included in this study. Each patient underwent an evaluation of the ocular surface, using the Ocular Surface Disease Index, tear film breakup time (TBUT), corneal and conjunctival staining (Oxford scale), and Schirmer I test. Using the tear film analysis program of the Optical Quality Analysis System, we recorded the objective scatter index (OSI) every 0.5 seconds within a 20-second period with the subjects asked to blink freely. Several parameters were established to evaluate the dynamic alterations of optical quality and the effects of blinks: OSI standard deviation (SD), ΔOSI, ΔOSI/time, blinking change (BC), blinking frequency (BF), and tolerant limitation (TL). RESULTS: Patients with DED had significant alterations of optical quality compared to control subjects. The ΔOSI, ΔOSI/time, BC, and BF were significantly higher and TL was significantly lower in DED patients than controls. Furthermore, the ΔOSI and ΔOSI/time were also significantly higher in patients with severe DED than patients with mild disease. In univariate analysis, both TBUT and corneal staining were correlated with ΔOSI, ΔOSI/time, and BC. In multivariate analysis, ΔOSI/time was correlated to the corneal staining score. CONCLUSIONS: The double-pass system allowed the monitoring of the dynamic changes of optical quality in patients with DED. Optical quality should be evaluated in patients with DED because these alterations cannot be determined from the classical DED clinical tests.
PURPOSE: To evaluate the dynamic changes of optical quality in patients with dry eye disease (DED) by using a double-pass system. METHODS: Fifty-six patients with DED and 35 control subjects were included in this study. Each patient underwent an evaluation of the ocular surface, using the Ocular Surface Disease Index, tear film breakup time (TBUT), corneal and conjunctival staining (Oxford scale), and Schirmer I test. Using the tear film analysis program of the Optical Quality Analysis System, we recorded the objective scatter index (OSI) every 0.5 seconds within a 20-second period with the subjects asked to blink freely. Several parameters were established to evaluate the dynamic alterations of optical quality and the effects of blinks: OSI standard deviation (SD), ΔOSI, ΔOSI/time, blinking change (BC), blinking frequency (BF), and tolerant limitation (TL). RESULTS:Patients with DED had significant alterations of optical quality compared to control subjects. The ΔOSI, ΔOSI/time, BC, and BF were significantly higher and TL was significantly lower in DED patients than controls. Furthermore, the ΔOSI and ΔOSI/time were also significantly higher in patients with severe DED than patients with mild disease. In univariate analysis, both TBUT and corneal staining were correlated with ΔOSI, ΔOSI/time, and BC. In multivariate analysis, ΔOSI/time was correlated to the corneal staining score. CONCLUSIONS: The double-pass system allowed the monitoring of the dynamic changes of optical quality in patients with DED. Optical quality should be evaluated in patients with DED because these alterations cannot be determined from the classical DED clinical tests.
Authors: Joaquín Fernández; Manuel Rodríguez-Vallejo; Javier Martínez; Ana Tauste; Javier García-Montesinos; David P Piñero Journal: Graefes Arch Clin Exp Ophthalmol Date: 2018-04-18 Impact factor: 3.117
Authors: Fen Ye; Feng Jiang; Yan Lu; Chun Yan Xue; Xiao Min Zhu; Yan Wu; Zhen Ping Huang Journal: Indian J Ophthalmol Date: 2019-05 Impact factor: 1.848
Authors: María García-Montero; Laura Rico-Del-Viejo; Irene Martínez-Alberquilla; Jose Luis Hernández-Verdejo; Amalia Lorente-Velázquez; David Madrid-Costa Journal: J Ophthalmol Date: 2019-07-09 Impact factor: 1.909